They took India into account which should have been thrown out. The drug itself nothing was wrong with it. Figures FDA couldn't find their nose from their butt from the ground. Hoping at least now someone merges to help BIOD as they cannot go through that many more trials without financing or they will dilute the stock. JMHO
Yep that is going to have to be my strategy now. Buy on dips and wait. At least it was not declined. So I am cool with letter they should be able to correct what they want.